Preclinical and clinical properties of trimegestone: a potent and selective progestin.

about

A new strategy for selective targeting of progesterone receptor with passive antagonists.Contraceptives with novel benefits.Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus.

P2860

Q33633141-50EA4F3A-1EFC-42A1-A212-8AF194466C55 Q37965736-3DBC2875-CD33-4A35-9360-F7F6056681E6 Q46538025-DE8D90DD-8326-4100-807D-DECF164736DB

P2860

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

Item

http://www.wikidata.org/entity/Q36872678

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

@en

type

Item

label

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

@en

prefLabel

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

@en

P1476

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

@en

P2093

Phillipe Bouchard

http://www.w3.org/2001/XMLSchema#string

Regine Sitruk-Ware

http://www.w3.org/2001/XMLSchema#string

Ronald Bossemeyer

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Conception and pharmacodynamic profile of drospirenone

Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone

The pharmacological profile of a novel norpregnance progestin (trimegestone).

Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia.

Progestogens in hormonal replacement therapy: new molecules, risks, and benefits.

Estrogen plus progestin and the risk of coronary heart disease.

The preclinical biology of a new potent and selective progestin: trimegestone.

Pharmacological profile of progestins.

Hormone replacement therapy and breast cancer: a qualitative review.

P304

310-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590701267727

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17616854

http://www.w3.org/2001/XMLSchema#string

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

about

P2860

P2860

Preclinical and clinical properties of trimegestone: a potent and selective progestin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698